Equities researchers at StockNews.com began coverage on shares of SemiLEDs (NASDAQ:LEDS – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the semiconductor company’s stock.
SemiLEDs Stock Up 1.8 %
LEDS stock opened at $1.48 on Friday. SemiLEDs has a one year low of $0.92 and a one year high of $2.29. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.34 and a current ratio of 0.85. The firm’s fifty day moving average is $1.26 and its 200 day moving average is $1.31. The firm has a market cap of $10.64 million, a PE ratio of -3.99 and a beta of 1.06.
Hedge Funds Weigh In On SemiLEDs
An institutional investor recently bought a new position in SemiLEDs stock. Garden State Investment Advisory Services LLC acquired a new stake in SemiLEDs Co. (NASDAQ:LEDS – Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 377,201 shares of the semiconductor company’s stock, valued at approximately $443,000. Garden State Investment Advisory Services LLC owned approximately 5.23% of SemiLEDs at the end of the most recent reporting period. Institutional investors own 76.29% of the company’s stock.
SemiLEDs Company Profile
SemiLEDs Corporation develops, manufactures, and sells light emitting diode (LED) chips, LED components, and LED modules and systems in the United States, Taiwan, the Netherlands, Germany, Japan, and internationally. The company also sells enhanced vertical, LED product series in blue, white, green, and UV; LED chips to packagers or distributors; and lighting products primarily to original design manufacturers of lighting products and the end-users of lighting devices, as well as packs and sells its LED chips.
Featured Articles
- Five stocks we like better than SemiLEDs
- Most Volatile Stocks, What Investors Need to Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Calculate Inflation Rate
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for SemiLEDs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SemiLEDs and related companies with MarketBeat.com's FREE daily email newsletter.